Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit.

OBJECTIVE High incidence, rising admission rates, and relatively ineffective therapies make the management of bronchiolitis controversial. Since 1980, the rate of hospitalization for children with bronchiolitis has increased by nearly 250%, whereas mortality rates for the disease have remained constant. It has been speculated that the increasing use of pulse oximetry has lowered the threshold for admission and may have contributed to the rise in bronchiolitis-related admissions. The objective of this study was to describe pediatric emergency medicine physicians' management preferences regarding infants with moderately severe bronchiolitis and to assess the influence of specific differences in oxygen saturation as measured by pulse oximetry (SpO2) and respiratory rate (RR) on the decision to admit. METHODS Physicians who are members of the American Academy of Pediatrics Section of Emergency Medicine and living in the United States were randomized into 4 groups and mailed a survey that contained 1 of 4 vignettes. Vignettes were identical except for given SpO2 values (94% or 92%) and RR (50/min or 65/min). Subjects were asked to answer questions regarding laboratory tests, treatment options, and the decision to admit for the patient in their vignette. RESULTS We received completed surveys from 519 (64%) of the 812 physicians contacted. Most respondents recommended use of bronchodilators (96%), nasal suction (82%), and supplemental oxygen (57%). Few respondents recommended decongestants (9%), steroids (8%), or antibiotics (2%). When asked to rank therapies, respondents gave nasal suction 182 number 1 votes; bronchodilators received 164. The decision to admit varied with SpO2 and RR. Forty-three percent of respondents who received a vignette featuring SpO2 of 94% and a RR of 50/min recommended admission for the infant in their vignette. Fifty-eight percent recommended admission when the vignette SpO2 was 94% and RR was 65/min (chi2 = 5.021). Respondents who received a vignette with SpO2 of 92% were nearly twice as likely to recommend admission: 83% recommended admission when vignette RR was 50/min, and 85% recommended admission when vignette RR was 65/min (chi2 = 0.126). CONCLUSIONS When treating infants with moderately severe bronchiolitis, pediatricians who work in emergency departments frequently use bronchodilators and nasal suction, 2 practices for which supporting data are either conflicting (bronchodilators) or nonexistent (nasal suction). In addition, their decisions to admit differ markedly on the basis of only a 2% difference in SpO2. It is possible that increased reliance on pulse oximetry has contributed to the increase in bronchiolitis hospitalization rates seen during the past 2 decades.

[1]  P. Brand,et al.  Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. , 1997, Thorax.

[2]  P. Schweich,et al.  The use of nebulized albuterol in wheezing infants. , 1992, Pediatric emergency care.

[3]  S. Dowell,et al.  Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile. , 1996, The Pediatric infectious disease journal.

[4]  E. Kerem,et al.  Efficacy of corticosteroids in acute bronchiolitis: Short‐term and long‐term follow‐up , 1998, Pediatric pulmonology.

[5]  S. McMahon,et al.  The Use of Albuterol in Hospitalized Infants With Bronchiolitis , 1998, Pediatrics.

[6]  F. Martinez Present and future treatment of asthma in infants and young children. , 1999, The Journal of allergy and clinical immunology.

[7]  K. Carlsen,et al.  Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis. , 2000, Respiratory medicine.

[8]  H. Levison,et al.  Nebulized albuterol in acute bronchiolitis. , 1990, The Journal of pediatrics.

[9]  T. Klassen,et al.  Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. , 1997, The Journal of pediatrics.

[10]  L. Yamamoto,et al.  Changes in the treatment of wheezing children in the emergency department. , 1993, The American journal of emergency medicine.

[11]  C. Poets,et al.  Noninvasive monitoring of oxygenation in infants and children: practical considerations and areas of concern. , 1994, Pediatrics.

[12]  I. Strannegård,et al.  Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. , 1993, Archives of disease in childhood.

[13]  J W Peabody,et al.  Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. , 2000, JAMA.

[14]  T. Permutt,et al.  Efficacy of albuterol in the management of bronchiolitis. , 1994, Pediatrics.

[15]  C. Nathan,et al.  Neonatal rhinitis. , 1997, International Journal of Pediatric Otorhinolaryngology.

[16]  B. Chipps,et al.  Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. , 1993, The Pediatric infectious disease journal.

[17]  M. Korppi,et al.  The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. , 1995, Archives of pediatrics & adolescent medicine.

[18]  F. W. Denny,et al.  Acute lower respiratory tract infections in nonhospitalized children. , 1986, The Journal of pediatrics.

[19]  J. Kellner,et al.  Updated bronchodilator analysis. , 1999, Archives of Pediatrics & Adolescent Medicine.

[20]  S. Dowell,et al.  Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. , 1996, The Pediatric infectious disease journal.

[21]  T. Chambers,et al.  Bronchodilators for bronchiolitis? , 1993, Lancet.

[22]  E. Wang,et al.  Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. , 1992, Archives of disease in childhood.

[23]  C. Newth,et al.  The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis. , 2000, The Journal of pediatrics.

[24]  Glezen Wp Pathogenesis of bronchiolitis--epidemiologic considerations. , 1977 .

[25]  K N Shaw,et al.  Outpatient assessment of infants with bronchiolitis. , 1991, American journal of diseases of children.

[26]  W. P. Glezen,et al.  Pathogenesis of bronchiolitis--epidemiologic considerations. , 1977, Pediatric research.

[27]  J. Holm,et al.  Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. , 1999, Pediatrics.

[28]  R. Seifer,et al.  The efficacy of nebulized metaproterenol in wheezing infants and young children. , 1992, American journal of diseases of children.

[29]  F. Shann,et al.  Clinical findings and severity of acute bronchiolitis , 1990, The Lancet.

[30]  T. Klassen Recent advances in the treatment of bronchiolitis and laryngitis. , 1997, Pediatric clinics of North America.

[31]  A. Rebuck,et al.  The P90 as a clinically relevant landmark on the oxyhemoglobin dissociation curve. , 1988, The American review of respiratory disease.

[32]  M. Sears,et al.  PAEDIATRICS Bronchodilators for bronchiolitis? , 1993, The Lancet.

[33]  C. Derkay,et al.  Airway compromise from nasal obstruction in neonates and infants. , 1990, International journal of pediatric otorhinolaryngology.

[34]  A. Kaplan,et al.  Complement dependence of histamine release in chronic urticaria. , 1999, The Journal of allergy and clinical immunology.

[35]  R. Tanz,et al.  Dexamethasone in bronchiolitis: a randomised controlled trial , 1996, The Lancet.

[36]  E. Wang,et al.  Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. , 1997, Pediatrics.

[37]  I. Sánchez,et al.  Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis , 2001, Pediatric pulmonology.

[38]  V. Chernick,et al.  Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. , 1993, The Journal of pediatrics.

[39]  R. Holman,et al.  Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. , 2001, The Journal of infectious diseases.

[40]  J. Eisenkraft,et al.  Anesthesia Equipment: Principles and Applications , 1996 .

[41]  J. Devincenzo Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases). , 1997, Advances in pediatric infectious diseases.

[42]  R. Black,et al.  Oral versus nebulized albuterol in the management of bronchiolitis in Egypt. , 1994, The Journal of pediatrics.

[43]  S. Mason,et al.  Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis , 2000, Archives of disease in childhood.

[44]  T. Klassen,et al.  Randomized trial of salbutamol in acute bronchiolitis. , 1991, The Journal of pediatrics.

[45]  P. A. Schad,et al.  Pattern of drug usage in bronchiolitis , 1994, Journal of clinical pharmacy and therapeutics.

[46]  R. Holman,et al.  Bronchiolitis-associated hospitalizations among US children, 1980-1996. , 1999, JAMA.

[47]  W. Mower,et al.  Pulse oximetry as a fifth pediatric vital sign. , 1997, Pediatrics.

[48]  R. Newcomb Use of adrenergic bronchodilators by pediatric allergists and pulmonologists. , 1989, American journal of diseases of children.

[49]  W. Mower,et al.  Effect of routine emergency department triage pulse oximetry screening on medical management. , 1995, Chest.

[50]  T. Konrad,et al.  Reported response rates to mailed physician questionnaires. , 2001, Health services research.

[51]  R. Horwitz,et al.  Efficacy of β2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis , 1997 .

[52]  M. Kattan,et al.  A study of pediatric house staff's knowledge of pulse oximetry. , 1994, Pediatrics.

[53]  C. Heilman From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. , 1990, The Journal of infectious diseases.

[54]  J. Kellner,et al.  Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. , 1996, Archives of pediatrics & adolescent medicine.

[55]  Michelle M. Garrison,et al.  Systemic Corticosteroids in Infant Bronchiolitis: A Meta-analysis , 2000, Pediatrics.